Cash Flow Statement

Amortizatization of Intangibles Amortizatization of Intangibles Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Issued Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization EBIAT Leases Long-Term Debt Issuances Long-Term Debt Repayments Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Other Gross PP&E Adjustments Preferred Shares Issued Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - Other Shares Issued Shares Outstanding Shares Outstanding

Ratios

Alto Neuroscience (ANRO) Long-Term Debt Repayments (2025)

Alto Neuroscience has reported Long-Term Debt Repayments over the past 1 years, most recently at $10.2 million for Q1 2025.

Quarterly results put Long-Term Debt Repayments at $10.2 million for Q1 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was $10.2 million (changed N/A YoY), and the annual figure for FY2025 was $10.2 million, changed.
Long-Term Debt Repayments reached $10.2 million in Q1 2025 per ANRO's latest filing.
Across five years, Long-Term Debt Repayments topped out at $10.2 million in Q1 2025 and bottomed at $10.2 million in Q1 2025.